Basic Info
  • Grade: Pharmaceutical Grade

    Factory Location: China

    Main Sales Markets: North America,Central/South America,Eastern Europe,Middle East,Africa

  • Sample Provided: yes

    Payment Terms: L/L

    Ticagrelor tablets are indicated to reduce the risk of cardiovascular death, myocardial infarction (MI), and stroke in patients with acute coronary syndrome (ACS) or a history of MI. For at least the first 12 months following ACS, it is superior to clopidogrel.

    Ticagrelor tablets also reduce the risk of stent thrombosis in patients who have been stented for treatment of ACS

Send your message to this supplier
  • From:
  • To:
    Rensin Chemicals Limited
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service